Skip to main content
. 2021 May 18;22(10):5297. doi: 10.3390/ijms22105297

Figure 2.

Figure 2

Cholesteryl ester (CE), diacylglycerol (DG), triacylglycerol (TG) and free cholesterol (FC) in non-tumor liver tissues of patients with HBV, HCV and HBV/HCV infection. (A) Median levels of CE, DG, TG and FC in HBV infected patients stratified for steatosis grade (<5%, seven patients; 5–33% one patient and 34–66% two patients). Lipids changed with increasing steatosis grade are in bold; (B) Median levels of CE, DG, TG and FC in HCV infected patients stratified for steatosis grade (<5%, six patients; 5–33% two patients, 34–66% one patient and 67–100% one patient; steatosis grade of one patients was unknown). Lipids changed with increasing steatosis grade are in bold; (C) Levels of CE, DG, TG and FC in non-tumor liver tissues of patients with HBV, HCV and HBV/HCV infection; (D) Saturated (Sat), monounsaturated (MU) and polyunsaturated (PU) DGs in non-tumor liver tissues of patients with HBV, HCV and HBV/HCV infection. Significant different lipid classes between HBV and HCV patients are in bold. * p < 0.05 (One-way ANOVA).